collaboration
centogene
increases
testing
capacities
netherlands
cambridge
mass
rostock
germany
berlin
baarn
netherlands
globe
newswire
centogene
nasdaq
cntg
company
focused
rare
diseases
transforms
clinical
genetic
data
actionable
information
patients
physicians
pharmaceutical
companies
dutch
medical
laboratory
specialized
analysis
field
clinical
chemistry
hematology
medical
microbiology
medical
immunology
pathological
diagnostics
today
announced
joined
forces
provide
increased
testing
communities
throughout
netherlands
partnership
comes
netherlands
currently
facing
shortage
testing
capacities
among
rapidly
increasing
number
infections
companies
see
part
commitment
provide
easily
accessible
testing
solutions
underlining
importance
collaboration
innovation
keep
communities
economies
healthy
part
agreement
offering
coronavirus
testing
laboratory
netherlands
since
march
teamed
centogene
major
provider
testing
germany
provide
increased
testing
services
throughout
netherlands
centogene
assist
providing
dry
plastic
swab
oropharyngeal
swabbing
followed
reverse
transcription
polymerase
chain
reaction
analyses
samples
laboratories
working
together
leverage
already
existing
technologies
workflows
companies
hope
greatly
support
netherlands
testing
efforts
arndt
rolfs
ceo
centogene
said
truly
committed
helping
fight
novel
coronavirus
netherlands
working
together
confident
containing
preventing
pandemic
collaboration
willingness
think
outside
box
really
chance
fighting
joint
statement
maarten
cuppen
ceo
albert
zwart
founder
cmo
said
significant
expansion
available
tests
able
provide
netherlands
sharing
expertise
able
make
substantial
contribution
preventing
outbreaks
keeping
economy
communities
collaborative
testing
solution
centogene
dedicated
working
together
provide
quality
testing
global
community
test
detects
infection
detecting
specific
rna
molecules
originate
genome
coronavirus
diagnostic
procedure
includes
rna
extraction
transcription
rna
complementary
dna
cdna
means
reverse
transcription
amplification
multiplication
cdna
means
polymerase
chain
reaction
pcr
presence
cdna
amplification
product
shows
virus
particles
sample
thus
indicates
active
infection
method
used
based
published
method
drosten
charité
berlin
test
referred
documents
charité
test
analytical
steps
particular
target
sequences
used
detect
viral
rna
correspond
exactly
corman
et
al
pmid
validated
interlaboratory
tests
well
cooperation
laboratory
drosten
test
also
validated
centogene
cap
clia
iso
certified
analytical
laboratory
received
emergency
use
authorization
eua
united
states
food
drug
administration
fda
use
authorized
laboratories
samples
collected
via
partners
collected
using
centogene
dry
plastic
swab
oropharyngeal
swab
sampling
recent
study
beetz
skrahina
et
al
pmid
underlined
oropharyngeal
swabs
including
collected
individuals
detect
appropriate
alternative
one
performed
healthcare
professional
nasopharyngeal
swabs
oropharyngeal
swabs
sample
collected
received
results
within
hours
combining
validated
medical
tools
peace
mind
work
keep
communities
economies
open
samples
brought
centogene
laboratory
analyses
results
returned
deliver
test
reports
patients
directly
founded
albert
zwart
request
university
medical
center
utrecht
part
laboratory
center
umc
utrecht
innovative
medical
laboratory
specialized
analysis
fields
clinical
trials
clinical
chemistry
hematology
medical
microbiology
medical
immunology
pathological
diagnostics
performs
laboratory
analyzes
general
practitioners
occupational
health
safety
services
health
centers
government
agencies
laboratories
companies
thanks
intricate
network
deployment
courier
service
offerings
available
nationwide
committed
times
ensure
physicians
maintain
complete
control
practice
patient
care
centogene
centogene
engages
diagnosis
research
around
rare
diseases
transforming
clinical
genetic
data
actionable
information
patients
physicians
pharmaceutical
companies
goal
bring
rationality
treatment
decisions
accelerate
development
new
orphan
drugs
using
extensive
rare
disease
knowledge
including
epidemiological
clinical
data
well
innovative
biomarkers
centogene
developed
global
proprietary
rare
disease
platform
based
data
repository
billion
weighted
data
points
approximately
patients
representing
different
countries
august
company
platform
includes
epidemiologic
phenotypic
genetic
data
reflects
global
population
also
biobank
patients
blood
samples
centogene
believes
represents
platform
comprehensively
analyzes
data
improve
understanding
rare
hereditary
diseases
aid
identification
patients
improve
pharmaceutical
partners
ability
bring
orphan
drugs
market
august
company
collaborated
pharmaceutical
partners
covering
different
rare
diseases
important
notice
disclaimer
press
release
contains
statements
constitute
forward
looking
statements
term
defined
united
states
private
securities
litigation
reform
act
including
statements
express
company
opinions
expectations
beliefs
plans
objectives
assumptions
projections
regarding
future
events
future
results
contrast
statements
reflect
historical
facts
examples
include
discussion
strategies
financing
plans
growth
opportunities
market
growth
cases
identify
statements
terminology
anticipate
intend
believe
estimate
plan
seek
project
expect
may
would
could
negative
terms
similar
expressions
forward
looking
statements
based
management
current
beliefs
assumptions
information
currently
available
company
however
statements
guarantee
performance
place
undue
reliance
statements
statements
subject
many
risks
uncertainties
variable
circumstances
negative
worldwide
economic
conditions
ongoing
instability
volatility
worldwide
financial
markets
effects
pandemic
business
results
operations
possible
changes
current
proposed
legislation
regulations
governmental
policies
pressures
increasing
competition
consolidation
industry
expense
uncertainty
regulatory
approval
including
food
drug
administration
reliance
third
parties
collaboration
partners
including
ability
manage
growth
enter
new
client
relationships
dependency
rare
disease
industry
ability
manage
international
expansion
reliance
key
personnel
reliance
intellectual
property
protection
fluctuations
operating
results
due
effect
exchange
rates
factors
risks
uncertainties
may
cause
statements
inaccurate
readers
cautioned
place
undue
reliance
statements
many
risks
outside
company
control
could
cause
actual
results
differ
materially
thought
would
occur
statements
included
press
release
made
date
hereof
company
undertake
specifically
declines
obligation
update
statements
publicly
announce
results
revisions
statements
reflect
future
events
developments
except
required
law
information
please
refer
risk
factors
section
annual
report
year
ended
december
form
filed
sec
april
form
containing
financial
results
three
months
ended
march
filed
sec
june
current
reports
documents
filed
securities
exchange
commission
sec
may
get
documents
visiting
edgar
sec
website
media
contact
centogene
ben
legg
corporate
communications
maarten
cuppen
chief
executive
officer
fti
consulting
bridie
lawlor
